Cargando…

Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period

BACKGROUND: The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mammina, Caterina, Calà, Cinzia, Bonura, Celestino, Di Carlo, Paola, Aleo, Aurora, Fasciana, Teresa, Giammanco, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473248/
https://www.ncbi.nlm.nih.gov/pubmed/22713430
http://dx.doi.org/10.1186/1476-0711-11-17
_version_ 1782246734484733952
author Mammina, Caterina
Calà, Cinzia
Bonura, Celestino
Di Carlo, Paola
Aleo, Aurora
Fasciana, Teresa
Giammanco, Anna
author_facet Mammina, Caterina
Calà, Cinzia
Bonura, Celestino
Di Carlo, Paola
Aleo, Aurora
Fasciana, Teresa
Giammanco, Anna
author_sort Mammina, Caterina
collection PubMed
description BACKGROUND: The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis of non multiresistant MRSA isolates from four acute general hospitals was performed in Palermo, Italy, during a one year period. METHODS: For the purpose of the study, MRSA isolates were defined as non multiresistant when they were susceptible to at least three classes of non β-lactam antibiotics. Seventy-five isolates were submitted to antimicrobial susceptibility testing, multilocus sequence typing (MLST) and polymerase chain reaction (PCR) for SCCmec, accessory gene regulator (agr) groups, arginine catabolic mobile element (ACME) and Panton Valentine leukocidin (PVL) toxin genes. For epidemiological typing, Multiple-Locus Variable-Number Tandem Repeat Fingerprinting (MLVF) was performed on all isolates and pulsed field gel electrophoresis (PFGE) on ST8 isolates. RESULTS: Non multiresistant MRSA isolates were isolated from all hospitals. Resistances to ciprofloxacin, macrolides and tetracycline were the most prevalent. MLST attributed 46 isolates with ST22, 13 with ST8, eight with ST1, three with ST50 and three with ST398. SCCmec type IV was found in all isolates. PVL was detected in one ST22 isolate. All isolates tested negative for the ACME element. MLVF identified 31 different patterns, some subtype clusters ranging in size between two and 22 isolates. The closely related PFGE patterns of the ST8 isolates differed from USA300. CONCLUSIONS: A polyclonal circulation of non multiresistant MRSA along with blurring of boundaries between healthcare associated (HA)-MRSA and community associated (CA)-MRSA appear to be occurring in our epidemiological setting. A better understanding of spread of MRSA with the support of molecular typing can provide invaluable information in the epidemiological, microbiological and clinical fields.
format Online
Article
Text
id pubmed-3473248
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34732482012-10-18 Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period Mammina, Caterina Calà, Cinzia Bonura, Celestino Di Carlo, Paola Aleo, Aurora Fasciana, Teresa Giammanco, Anna Ann Clin Microbiol Antimicrob Research BACKGROUND: The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis of non multiresistant MRSA isolates from four acute general hospitals was performed in Palermo, Italy, during a one year period. METHODS: For the purpose of the study, MRSA isolates were defined as non multiresistant when they were susceptible to at least three classes of non β-lactam antibiotics. Seventy-five isolates were submitted to antimicrobial susceptibility testing, multilocus sequence typing (MLST) and polymerase chain reaction (PCR) for SCCmec, accessory gene regulator (agr) groups, arginine catabolic mobile element (ACME) and Panton Valentine leukocidin (PVL) toxin genes. For epidemiological typing, Multiple-Locus Variable-Number Tandem Repeat Fingerprinting (MLVF) was performed on all isolates and pulsed field gel electrophoresis (PFGE) on ST8 isolates. RESULTS: Non multiresistant MRSA isolates were isolated from all hospitals. Resistances to ciprofloxacin, macrolides and tetracycline were the most prevalent. MLST attributed 46 isolates with ST22, 13 with ST8, eight with ST1, three with ST50 and three with ST398. SCCmec type IV was found in all isolates. PVL was detected in one ST22 isolate. All isolates tested negative for the ACME element. MLVF identified 31 different patterns, some subtype clusters ranging in size between two and 22 isolates. The closely related PFGE patterns of the ST8 isolates differed from USA300. CONCLUSIONS: A polyclonal circulation of non multiresistant MRSA along with blurring of boundaries between healthcare associated (HA)-MRSA and community associated (CA)-MRSA appear to be occurring in our epidemiological setting. A better understanding of spread of MRSA with the support of molecular typing can provide invaluable information in the epidemiological, microbiological and clinical fields. BioMed Central 2012-06-19 /pmc/articles/PMC3473248/ /pubmed/22713430 http://dx.doi.org/10.1186/1476-0711-11-17 Text en Copyright ©2012 Mammina et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mammina, Caterina
Calà, Cinzia
Bonura, Celestino
Di Carlo, Paola
Aleo, Aurora
Fasciana, Teresa
Giammanco, Anna
Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title_full Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title_fullStr Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title_full_unstemmed Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title_short Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period
title_sort polyclonal non multiresistant methicillin resistant staphylococcus aureus isolates from clinical cases of infection occurring in palermo, italy, during a one-year surveillance period
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473248/
https://www.ncbi.nlm.nih.gov/pubmed/22713430
http://dx.doi.org/10.1186/1476-0711-11-17
work_keys_str_mv AT mamminacaterina polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT calacinzia polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT bonuracelestino polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT dicarlopaola polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT aleoaurora polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT fascianateresa polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod
AT giammancoanna polyclonalnonmultiresistantmethicillinresistantstaphylococcusaureusisolatesfromclinicalcasesofinfectionoccurringinpalermoitalyduringaoneyearsurveillanceperiod